Breakdown of cartilage proteoglycan in a tissue culture model of rheumatoid arthritis
- PMID: 6838906
- DOI: 10.1016/0304-4165(83)90151-4
Breakdown of cartilage proteoglycan in a tissue culture model of rheumatoid arthritis
Abstract
Proteoglycan breakdown was studied in a coculture model which mimics the confrontation between synovium and cartilage that occurs in rheumatoid arthritis. Bovine nasal-septum cartilage discs radioactively labeled (35SO2-4 with or without [3H]glucosamine) and 'chased' in non-radioactive medium were cultured in contact with minced rheumatoid synovial membranes for intervals up to 8 days. Synovium-stimulated (2-3-fold) cartilage breakdown was unaffected by ascorbate supplementation. Labeled products (small molecules plus proteoglycan complexes) in culture media were characterized by chromatographic, sedimentation and enzymic digestion methods. Breakdown was dominated by the release of a range of proteoglycan products, fully disaggregated and incapable of reaggregation with added hyaluronate. Because constituent glycosaminoglycans were of uniform size, proteoglycan polydispersity was attributed to differences in core protein length. Hydrocortisone inhibited degradation and partially prevented the shift of proteoglycans to lower average molecular weight. An additional breakdown pattern occasionally noted during the initial 48 h of coculture was characterized by release of a subpopulation of low charge-density proteoglycan bearing shortened glycosaminoglycan chains, consistent with glycosidase action. We conclude that rheumatoid synovia exhibit two distinct cartilage degradative potencies in vitro that may be important in vivo: (a) A variable hyaluronidase-like activity at early culture times, and (b) a dominant proteolytic activity generating an array of disaggregated proteoglycan products that differ largely on the basis of their core lengths. The response to hydrocortisone is consistent with inhibition of proteolysis through the stabilization of cellular membranes.
Similar articles
-
A tissue-culture model of cartilage breakdown in rheumatoid arthritis. Quantitative aspects of proteoglycan release.Biochem J. 1979 May 15;180(2):403-12. doi: 10.1042/bj1800403. Biochem J. 1979. PMID: 486116 Free PMC article.
-
Inhibition of cartilage breakdown by hydrocortisone in a tissue culture model of rheumatoid arthritis.Ann Rheum Dis. 1983 Jun;42(3):323-30. doi: 10.1136/ard.42.3.323. Ann Rheum Dis. 1983. PMID: 6859964 Free PMC article.
-
Antibody to interleukin 1 inhibits the cartilage degradative and thymocyte proliferative actions of rheumatoid synovial culture medium.J Rheumatol. 1990 Dec;17(12):1600-7. J Rheumatol. 1990. PMID: 2084232
-
A tissue culture model of cartilage breakdown in rheumatoid arthritis. III. Effects of antirheumatic drugs.Arthritis Rheum. 1979 Aug;22(8):877-85. doi: 10.1002/art.1780220811. Arthritis Rheum. 1979. PMID: 111678
-
Metabolism of cartilage proteoglycans in health and disease.Biomed Res Int. 2014;2014:452315. doi: 10.1155/2014/452315. Epub 2014 Jul 3. Biomed Res Int. 2014. PMID: 25105124 Free PMC article. Review.
Cited by
-
Co-culture with infrapatellar fat pad differentially stimulates proteoglycan synthesis and accumulation in cartilage and meniscus tissues.Connect Tissue Res. 2017 Sep;58(5):447-455. doi: 10.1080/03008207.2016.1245728. Epub 2016 Oct 11. Connect Tissue Res. 2017. PMID: 27726455 Free PMC article.
-
Matrix depletion of young and old human articular cartilage by cultured autologous synovium fragments: a chondrocyte-independent effect.Rheumatol Int. 1985;5(4):169-73. doi: 10.1007/BF00541518. Rheumatol Int. 1985. PMID: 4048758
-
What's happened to catabolin?Rheumatol Int. 1987;7(4):141-5. doi: 10.1007/BF00270361. Rheumatol Int. 1987. PMID: 3313662 Review.
-
Cyclic AMP-regulating agents inhibit endotoxin-mediated cartilage degradation.Biochem J. 1987 May 15;244(1):63-8. doi: 10.1042/bj2440063. Biochem J. 1987. PMID: 2444211 Free PMC article.
-
Effects of anti-inflammatory drugs on cartilage recovery from catabolin-induced degradation.Agents Actions. 1987 Jun;21(1-2):149-59. doi: 10.1007/BF01974935. Agents Actions. 1987. PMID: 3115068
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical